156 related articles for article (PubMed ID: 27536069)
1. Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome.
Kiałka M; Milewicz T; Sztefko K; Rogatko I; Majewska R
Drug Des Devel Ther; 2016; 10():2483-90. PubMed ID: 27536069
[TBL] [Abstract][Full Text] [Related]
2. Pressure pain threshold and β-endorphins plasma level are higher in lean polycystic ovary syndrome women.
Kiałka M; Milewicz T; Mrozińska S; Rogatko I; Sztefko K; Majewska R
Minerva Endocrinol; 2017 Dec; 42(4):297-305. PubMed ID: 27603705
[TBL] [Abstract][Full Text] [Related]
3. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
4. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Aessopos A; Paterakis T; Katsikis I; Panidis D
Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
7. [Metformin and changes in blood pressure and heart rate in lean patients with polycystic ovary syndrome (PCOS)--preliminary study].
Tomczyk R; Ociepka A; Kiałka M; Milewicz T; Migacz K; Kowalczuk A; Klocek M
Przegl Lek; 2015; 72(6):302-5. PubMed ID: 26817338
[TBL] [Abstract][Full Text] [Related]
8. Proinsulin, adiponectin and hsCRP in reproductive age women with polycystic ovary syndrome (PCOS)--the effect of metformin treatment.
Kruszyńska A; Słowińska-Srzednicka J; Jeske W; Zgliczyński W
Endokrynol Pol; 2014; 65(1):2-10. PubMed ID: 24549596
[TBL] [Abstract][Full Text] [Related]
9. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
[TBL] [Abstract][Full Text] [Related]
10. Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study.
Stefanaki C; Bacopoulou F; Kandaraki E; Boschiero D; Diamandi-Kandarakis E
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31480705
[TBL] [Abstract][Full Text] [Related]
11. A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin.
Shigiyama F; Kumashiro N; Rikitake T; Usui S; Saegusa M; Kitamura M; Uchino H; Hirose T
Endocr J; 2016; 63(2):193-8. PubMed ID: 26765270
[TBL] [Abstract][Full Text] [Related]
12. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Luque-Ramírez M; Alvarez-Blasco F; Uriol Rivera MG; Escobar-Morreale HF
Hum Reprod; 2008 Jul; 23(7):1594-601. PubMed ID: 18375410
[TBL] [Abstract][Full Text] [Related]
13. Metformin monotherapy in lean women with polycystic ovary syndrome.
Kumari AS; Haq A; Jayasundaram R; Abdel-Wareth LO; Al Haija SA; Alvares M
Reprod Biomed Online; 2005 Jan; 10(1):100-4. PubMed ID: 15705302
[TBL] [Abstract][Full Text] [Related]
14. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
15. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
[TBL] [Abstract][Full Text] [Related]
16. Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment.
Cheng F; Zhao L; Wu Y; Huang T; Yang G; Zhang Z; Wu Y; Jia F; Wu J; Chen C; Liu D
Clin Endocrinol (Oxf); 2016 Mar; 84(3):386-93. PubMed ID: 26387747
[TBL] [Abstract][Full Text] [Related]
17. Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism.
Morteza Taghavi S; Rokni H; Fatemi S
Diab Vasc Dis Res; 2011 Jan; 8(1):47-8. PubMed ID: 21262871
[TBL] [Abstract][Full Text] [Related]
18. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
19. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
20. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
